Brian Cheng
Stock Analyst at J.P. Morgan
(4.51)
# 1,045
Out of 4,572 analysts
260
Total ratings
54.7%
Success rate
12.6%
Average return
Main Sectors:
Stocks Rated by Brian Cheng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STTK Shattuck Labs | Initiated Coverage: Buy | $10 | $7.09 | +41.04% | 1 | Jul 24, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $95 | $86.78 | +9.47% | 3 | Jul 21, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $200 → $205 | $188.75 | +8.61% | 15 | Jul 21, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $65 | $55.50 | +17.12% | 3 | Jul 16, 2026 | |
| TNGX Tango Therapeutics | Initiated Coverage: Buy | $46 | $27.45 | +67.58% | 1 | Jul 15, 2026 | |
| PTCT PTC Therapeutics | Maintained: Buy | $89 → $91 | $78.45 | +16.00% | 10 | Jul 13, 2026 | |
| TARA Protara Therapeutics | Maintained: Buy | n/a | $4.04 | - | 5 | Jun 30, 2026 | |
| IMNM Immunome | Maintained: Buy | n/a | $22.01 | - | 9 | Jun 29, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | n/a | $110.38 | - | 6 | Jun 25, 2026 | |
| ODTX Odyssey Therapeutics | Initiated Coverage: Buy | $26 | $17.67 | +47.14% | 1 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.62 | - | 4 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $47 | $39.37 | +19.38% | 11 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $40 | $35.10 | +13.96% | 23 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 | $11.10 | -27.93% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $106 → $113 | $135.43 | -16.56% | 22 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $7.29 | +297.81% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 → $14 | $19.53 | -28.32% | 15 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $31 | $23.03 | +34.61% | 2 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $71.12 | +34.98% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $1.82 | - | 8 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $46 | $19.33 | +138.03% | 6 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.91 | - | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.73 | - | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.12 | - | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 → $67 | $47.53 | +40.96% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.08 | - | 2 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.17 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $8.07 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $5.54 | - | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.22 | n/a | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.46 | n/a | 7 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.43 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $6 | $1.22 | n/a | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $6 | $8.42 | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.4266 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.1425 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $3.5 | $1.79 | n/a | 2 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $9.38 | n/a | 6 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.9455 | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $86 | $5.79 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.69 | n/a | 2 | Nov 2, 2021 |
Shattuck Labs
Jul 24, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $7.09
Upside: +41.04%
Arrowhead Pharmaceuticals
Jul 21, 2026
Maintained: Buy
Price Target: $95
Current: $86.78
Upside: +9.47%
Revolution Medicines
Jul 21, 2026
Maintained: Buy
Price Target: $200 → $205
Current: $188.75
Upside: +8.61%
TG Therapeutics
Jul 16, 2026
Maintained: Buy
Price Target: $65
Current: $55.50
Upside: +17.12%
Tango Therapeutics
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $27.45
Upside: +67.58%
PTC Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $89 → $91
Current: $78.45
Upside: +16.00%
Protara Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $4.04
Upside: -
Immunome
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $22.01
Upside: -
Kymera Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: n/a
Current: $110.38
Upside: -
Odyssey Therapeutics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $17.67
Upside: +47.14%
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $9.62
Upside: -
May 26, 2026
Maintained: Buy
Price Target: $35 → $47
Current: $39.37
Upside: +19.38%
May 26, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $35.10
Upside: +13.96%
May 13, 2026
Maintained: Sell
Price Target: $8
Current: $11.10
Upside: -27.93%
May 13, 2026
Maintained: Buy
Price Target: $106 → $113
Current: $135.43
Upside: -16.56%
May 13, 2026
Rated: Buy
Price Target: $29
Current: $7.29
Upside: +297.81%
May 11, 2026
Rated: Hold
Price Target: $13 → $14
Current: $19.53
Upside: -28.32%
May 11, 2026
Rated: Buy
Price Target: $30 → $31
Current: $23.03
Upside: +34.61%
May 11, 2026
Rated: Buy
Price Target: $96
Current: $71.12
Upside: +34.98%
Apr 16, 2026
Upgraded: Hold
Price Target: n/a
Current: $1.82
Upside: -
Apr 15, 2026
Maintained: Buy
Price Target: $47 → $46
Current: $19.33
Upside: +138.03%
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $25.91
Upside: -
Mar 13, 2026
Maintained: Sell
Price Target: n/a
Current: $2.73
Upside: -
Mar 3, 2026
Maintained: Buy
Price Target: n/a
Current: $23.12
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: $69 → $67
Current: $47.53
Upside: +40.96%
Dec 4, 2025
Reiterated: Sell
Price Target: n/a
Current: $1.08
Upside: -
Nov 20, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.17
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $8.07
Upside: -
Aug 15, 2025
Upgraded: Hold
Price Target: n/a
Current: $5.54
Upside: -
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.22
Upside: n/a
Sep 13, 2024
Rated: Hold
Price Target: n/a
Current: $3.46
Upside: n/a
Jul 15, 2024
Maintained: Hold
Price Target: n/a
Current: $1.43
Upside: n/a
May 2, 2024
Downgraded: Hold
Price Target: $16 → $6
Current: $1.22
Upside: n/a
Jun 1, 2023
Downgraded: Hold
Price Target: $20 → $6
Current: $8.42
Upside: n/a
Dec 16, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $0.4266
Upside: n/a
Dec 7, 2022
Downgraded: Sell
Price Target: n/a
Current: $0.1425
Upside: n/a
Apr 19, 2022
Maintained: Buy
Price Target: $33 → $3.5
Current: $1.79
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: $21 → $17
Current: $9.38
Upside: n/a
Apr 4, 2022
Reiterated: Buy
Price Target: $12
Current: $0.9455
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $93 → $86
Current: $5.79
Upside: n/a
Nov 2, 2021
Maintained: Buy
Price Target: $14
Current: $2.69
Upside: n/a